Relay Therapeutics, Inc. (RLAY) Tops Q1 EPS by 6c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q1 EPS of ($0.46), $0.06 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $7.68 million versus the consensus estimate of $37.5 thousand.

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Safe Pro wins $1.3M U.S. Army subcontract for AI landmine detection
• ADP weekly jobs estimate rises to 30,750 for week ending June 6